Emerald Advisers, LLC Neogenomics Inc Transaction History

Emerald Advisers, LLC

$2.36 Billion
Q1 2024

A detailed history of Emerald Advisers, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 1,905,904 shares of NEO stock, worth $26.1 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

1,905,904

Previous 1,897,814 0.43%

Holding current value

$26.1 Million

Previous $30.7 Million 2.43%

% of portfolio

1.27%

Previous 1.38%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$14.06 - $16.79 $113,745 - $135,831	8,090 Added 0.43%	1,905,904 $30 Million
Q4 2023 Feb 05, 2024	SELL	$11.67 - $20.73 $341,464 - $606,559	-29,260 Reduced 1.52%	1,897,814 $30.7 Million
Q3 2023 Oct 26, 2023	BUY	$12.15 - $17.85 $3.29 Million - $4.83 Million	270,855 Added 16.35%	1,927,074 $23.7 Million
Q2 2023 Jul 25, 2023	SELL	$14.1 - $19.83 $184,780 - $259,872	-13,105 Reduced 0.79%	1,656,219 $26.6 Million
Q1 2023 May 04, 2023	SELL	$9.09 - $19.45 $3.93 Million - $8.41 Million	-432,243 Reduced 20.57%	1,669,324 $29.1 Million

Q4 2022 Feb 03, 2023	SELL	$6.45 - $12.07 $245,177 - $458,804	-38,012 Reduced 1.78%	2,101,567 $19.4 Million
Q3 2022 Oct 25, 2022	BUY	$7.86 - $12.91 $7.28 Million - $12 Million	926,226 Added 76.34%	2,139,579 $18.4 Million
Q2 2022 Jul 29, 2022	BUY	$7.06 - $13.97 $863,021 - $1.71 Million	122,241 Added 11.2%	1,213,353 $9.89 Million
Q1 2022 Apr 29, 2022	BUY	$12.15 - $35.28 $2.5 Million - $7.26 Million	205,676 Added 23.23%	1,091,112 $13.3 Million
Q4 2021 Feb 02, 2022	SELL	$30.49 - $48.49 $575,102 - $914,618	-18,862 Reduced 2.09%	885,436 $30.2 Million
Q3 2021 Oct 28, 2021	BUY	$41.66 - $52.52 $1.34 Million - $1.7 Million	32,276 Added 3.7%	904,298 $43.6 Million
Q2 2021 Jul 29, 2021	SELL	$36.62 - $51.69 $11.4 Million - $16 Million	-310,360 Reduced 26.25%	872,022 $39.4 Million
Q1 2021 Apr 29, 2021	SELL	$41.56 - $59.88 $7 Million - $10.1 Million	-168,423 Reduced 12.47%	1,182,382 $57 Million
Q4 2020 Jan 29, 2021	SELL	$36.08 - $56.47 $525,000 - $821,694	-14,551 Reduced 1.07%	1,350,805 $72.7 Million
Q3 2020 Oct 28, 2020	SELL	$33.26 - $40.48 $2 Million - $2.44 Million	-60,199 Reduced 4.22%	1,365,356 $50.4 Million
Q2 2020 Jul 28, 2020	BUY	$24.21 - $31.02 $2.48 Million - $3.17 Million	102,257 Added 7.73%	1,425,555 $44.2 Million
Q1 2020 Apr 30, 2020	SELL	$20.5 - $34.53 $3.47 Million - $5.85 Million	-169,301 Reduced 11.34%	1,323,298 $36.5 Million
Q4 2019 Jan 29, 2020	SELL	$18.96 - $29.84 $4.65 Million - $7.32 Million	-245,220 Reduced 14.11%	1,492,599 $43.7 Million
Q3 2019 Oct 31, 2019	SELL	$19.12 - $26.24 $4.08 Million - $5.6 Million	-213,242 Reduced 10.93%	1,737,819 $33.2 Million
Q2 2019 Jul 31, 2019	BUY	$19.57 - $24.1 $1.41 Million - $1.74 Million	72,160 Added 3.84%	1,951,061 $42.8 Million
Q1 2019 May 01, 2019	SELL	$12.14 - $20.46 $362,913 - $611,631	-29,894 Reduced 1.57%	1,878,901 $38.4 Million
Q4 2018 Jan 30, 2019	BUY	$11.24 - $18.5 $2.66 Million - $4.38 Million	236,965 Added 14.17%	1,908,795 $24.1 Million
Q3 2018 Oct 31, 2018	BUY	$12.5 - $15.38 $3.72 Million - $4.57 Million	297,384 Added 21.64%	1,671,830 $25.7 Million
Q2 2018 Jul 31, 2018	BUY	$7.99 - $14.05 $870,103 - $1.53 Million	108,899 Added 8.6%	1,374,446 $18 Million
Q1 2018 Apr 26, 2018	SELL	$7.23 - $8.76 $1.15 Million - $1.39 Million	-158,716 Reduced 11.14%	1,265,547 $10.3 Million
Q4 2017 Feb 05, 2018	BUY	$8.02 - $11.18 $343,175 - $478,392	42,790 Added 3.1%	1,424,263 $12.6 Million
Q3 2017 Oct 30, 2017	BUY	$9.11 - $11.26 $12.6 Million - $15.6 Million	1,381,473	1,381,473 $15.4 Million

Others Institutions Holding NEO

# of Institutions

279

Shares Held

127M

Call Options Held

1.13M

Put Options Held

232K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.72B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Neogenomics Inc Transaction History